Gibbs Wealth Management acquired a new stake in IMAX Corporation (NYSE:IMAX – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 19,478 shares of the company’s stock, valued at approximately $740,000.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. CIBC Private Wealth Group LLC purchased a new position in shares of IMAX during the third quarter worth $27,000. Quarry LP grew its position in IMAX by 166.8% during the 4th quarter. Quarry LP now owns 875 shares of the company’s stock worth $32,000 after purchasing an additional 547 shares during the period. Caitong International Asset Management Co. Ltd grew its position in IMAX by 2,310.4% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,157 shares of the company’s stock worth $38,000 after purchasing an additional 1,109 shares during the period. Torren Management LLC purchased a new position in shares of IMAX during the 4th quarter valued at about $40,000. Finally, Aster Capital Management DIFC Ltd raised its stake in shares of IMAX by 863.0% during the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,666 shares of the company’s stock valued at $62,000 after buying an additional 1,493 shares during the last quarter. Institutional investors and hedge funds own 93.51% of the company’s stock.
IMAX News Roundup
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: IMAX reported better-than-expected second-quarter results, with EPS and revenue both topping Wall Street estimates, while management reaffirmed full-year guidance and highlighted margin expansion and network growth. IMAX Corporation Reports Second Quarter 2026 Results
- Positive Sentiment: Strong box-office traction for The Odyssey is boosting confidence that IMAX can sustain higher ticket sales and premium-screen utilization, with reports suggesting the film could be a transformational release for the company. The Odyssey is cleaning up for IMAX. Expect the momentum to continue
- Positive Sentiment: Analysts turned more bullish after earnings, with JPMorgan, Wells Fargo, Barrington, and Wedbush all raising price targets, and Wedbush reiterating Outperform on expectations for a stronger film pipeline, market-share gains, and international expansion. IMAX price target boosted by Wedbush on growth outlook
- Positive Sentiment: Investor attention is also being reinforced by unusual call-option activity and multiple stories about sold-out IMAX 70mm showings, signaling strong near-term demand sentiment around the stock. Imax’s CEO says it’s time to hike prices as tickets to ‘The Odyssey’ resell for $1,000
- Neutral Sentiment: IMAX disclosed a new regulatory risk tied to geopolitical, trade, and other global expansion challenges, which could matter over time but does not appear to be driving near-term trading. IMAX Confronts Rising Geopolitical, Regulatory and Trade Risks Threatening Global Expansion
Insider Buying and Selling
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on the company. JPMorgan Chase & Co. boosted their price objective on IMAX from $47.00 to $50.00 and gave the company an “overweight” rating in a report on Friday. Keefe, Bruyette & Woods reaffirmed a “market perform” rating and set a $60.00 target price on shares of IMAX in a report on Friday, May 22nd. Rosenblatt Securities reiterated a “buy” rating and set a $47.00 price target on shares of IMAX in a research report on Monday, July 20th. Wells Fargo & Company boosted their price target on IMAX from $41.00 to $45.00 and gave the company an “equal weight” rating in a report on Friday. Finally, Weiss Ratings upgraded IMAX from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, July 16th. Ten investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $50.36.
Get Our Latest Analysis on IMAX
IMAX Stock Performance
Shares of IMAX stock opened at $43.21 on Friday. The firm has a 50-day simple moving average of $39.99 and a two-hundred day simple moving average of $38.03. The company has a market cap of $2.38 billion, a P/E ratio of 60.02, a price-to-earnings-growth ratio of 1.61 and a beta of 0.37. IMAX Corporation has a fifty-two week low of $24.20 and a fifty-two week high of $45.88.
IMAX (NYSE:IMAX – Get Free Report) last released its quarterly earnings results on Thursday, July 23rd. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.30 by $0.13. The company had revenue of $102.84 million during the quarter, compared to analysts’ expectations of $96.09 million. IMAX had a return on equity of 15.65% and a net margin of 9.84%.IMAX’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.26 EPS. Equities research analysts forecast that IMAX Corporation will post 1.3 EPS for the current year.
IMAX Profile
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Featured Articles
- Five stocks we like better than IMAX
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
